Market cap
$6,044 Mln
Revenue (TTM)
$2,464 Mln
P/E Ratio
--
P/B Ratio
2.2
Div. Yield
0 %
| R1 RCM (RCM) | Psychemedics (PMD) | |
|---|---|---|
Market cap ($ Mln) |
6,044 | 16 |
Revenue ($ Mln) |
2,464 | 20 |
Net Profit ($ Mln) |
-61.20 | -3.00 |
Net Margin (%) |
-2.48 | -14.78 |
RoE (%) |
-2.17 | -51.08 |
Price to Earnings |
-- | -- |
Price-To-Book |
2.15 | 2.40 |
Income Statement ($ Mln)
| R1 RCM (RCM) | Psychemedics (PMD) | |
|---|---|---|
|
Operating Revenue
|
2,463.70 | 20.26 |
|
Cost of Revenue
|
1,991.60 | 12.49 |
|
Gross Profit
|
484.50 | 8.41 |
|
Operating Expenses
|
273.20 | 10.70 |
|
Operating Profit (EBIT)
|
136.30 | -2.93 |
|
Other Income
|
0.00 | 0.00 |
|
Profit before Tax
|
-57.70 | -2.95 |
|
Provision for Tax
|
3.50 | 0.04 |
|
Profit after Tax (Net Income)
|
-61.20 | -3.00 |
|
Minority Interest
|
0.00 | 0.00 |
|
Consolidated Profit
|
0.00 | 0.00 |
Liabilities ($ Mln)
| R1 RCM (RCM) | Psychemedics (PMD) | |
|---|---|---|
|
Shareholder's Funds
|
2,811.10 | 5.45 |
|
Minority Interest
|
0.00 | 0.00 |
|
Non-Current Liabilities
|
2,508.60 | 0.60 |
|
Current Liabilities
|
429.60 | 3.79 |
|
Total Liabilities
|
4,960.20 | 12.33 |
Assets ($ Mln)
| R1 RCM (RCM) | Psychemedics (PMD) | |
|---|---|---|
|
Non-Current Assets
|
4,980.40 | 3.79 |
|
Current Assets
|
768.90 | 6.05 |
|
Total Assets
|
4,960.20 | 12.33 |
|
Total Debt*
|
2,314.40 | 1.58 |
|
Net Current Assets
|
339.30 | 2.25 |
Cashflow ($ Mln)
| R1 RCM (RCM) | Psychemedics (PMD) | |
|---|---|---|
|
Cash From Operating Activities
|
340.10 | -1.48 |
|
Cash Flow from Investing Activities
|
-- | -- |
|
Cash from Financing Activities
|
-173.90 | -1.15 |
|
Net Cash Inflow / Outflow
|
-- | -- |
Ratios
Profitability Ratios
| R1 RCM (RCM) | Psychemedics (PMD) | |
|---|---|---|
|
ROCE (%)
|
0.07 | -35.63 |
|
ROE (%)
|
-2.17 | -51.08 |
|
ROA (%)
|
-1.06 | -18.09 |
|
EBIT Margin (%)
|
0.91 | -11.50 |
|
Net Margin (%)
|
-2.48 | -14.78 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 |
Growth Ratios
| R1 RCM (RCM) | Psychemedics (PMD) | |
|---|---|---|
|
Revenue Growth (%)
|
11.38 | -11.16 |
|
EBIT Growth (%)
|
-70.53 | 49.00 |
|
Net Profit Growth (%)
|
-73.86 | 23.15 |
|
EPS Growth (%)
|
-71.64 | 24.31 |
|
Book Value Growth (%)
|
10.06 | -28.42 |
Valuation Ratios
| R1 RCM (RCM) | Psychemedics (PMD) | |
|---|---|---|
|
Price / Earnings
|
1,446.17 | -4.14 |
|
Price / Book Value
|
1.73 | 2.58 |
|
Dividend Yield (%)
|
-- | -- |
|
EV/EBITDA
|
14.44 | -69.80 |
|
Market Cap ($ Cr)
|
-- | -- |
Solvency Ratios
| R1 RCM (RCM) | Psychemedics (PMD) | |
|---|---|---|
|
Debt to Equity
|
0.76 | 0.00 |
|
Short term debt to equity ratio
|
0.04 | 0.18 |
|
Current Ratio
|
1.79 | 1.59 |
|
Quick Ratio
|
1.79 | 1.59 |
|
Interest Coverage
|
0.64 | -172.65 |
Operating Efficiency Ratios
| R1 RCM (RCM) | Psychemedics (PMD) | |
|---|---|---|
|
Debtors to sales (%)
|
18.54 | 16.41 |
|
Asset Turnover
|
0.43 | 1.22 |
|
Receivable days
|
58.62 | 64.32 |
|
Inventory Days
|
0.00 | 0.00 |
|
Payable days
|
5.79 | 16.01 |
|
Cash Conversion Cycle
|
52.83 | 48.31 |